ProCE Banner Activity

Practical Insights on HBV Management, HDV screening, and HCC risk

Clinical Thought

Learn the answers to commonly asked questions about which patients with hepatitis B should be treated, which patients should be screened for hepatitis delta virus, and how to approach hepatocellular carcinoma screening in people with chronic hepatitis B.

Released: December 05, 2023

Share

Faculty

Paul Y. Kwo

Paul Y. Kwo, MD

Professor of Medicine
Director of Hepatology
Stanford University School of Medicine
Palo Alto, California

Ira Jacobson

Ira Jacobson, MD

Professor of Medicine
Director of Hepatology
NYU Langone Health
New York, New York

Tatyana Kushner

Tatyana Kushner, MD, MSCE

Associate Professor
Division of Liver Diseases
Icahn School of Medicine at Mount Sinai
New York, New York

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

This educational activity is supported by an educational grant from GlaxoSmithKline.

GlaxoSmithKline

Disclosure

Program Director

Paul Y. Kwo, MD

Professor of Medicine
Director of Hepatology
Stanford University School of Medicine
Palo Alto, California

Paul Y. Kwo, MD: consultant/advisor/speaker: Aligos, Drug Farm, Eiger, Gilead, Inventiva; researcher: Altimmune, Bristol Myers Squibb, Eiger, Gilead, Janssen, Madrigal, Novo Nordisk, Salix, Ultragenyx.

Primary Author

Ira Jacobson, MD

Professor of Medicine
Director of Hepatology
NYU Langone Health
New York, New York

Ira Jacobson, MD: researcher: Assembly Biosciences, Bristol-Myers Squibb, Eiger, Enanta, Genkyotex, Gilead, GlaxoSmithKline, Intercept, Janssen, Lilly, Merck, Mirum, Novo Nordisk; consultant/advisor: Aligos, Arbutus, Arrowhead, Galapagos, Gilead, GlaxoSmithKline, Intercept, Janssen, Merck, Roche, Takeda; data monitoring committee: Aligos, Altimmune, GlaxoSmithKline, Takeda.

Tatyana Kushner, MD, MSCE

Associate Professor
Division of Liver Diseases
Icahn School of Medicine at Mount Sinai
New York, New York

Tatyana Kushner, MD, MSCE: consultant/advisor/speaker: AbbVie, Eiger, Gilead, GlaxoSmithKline; researcher: Gilead.